iclaprim has been researched along with bc-3781 in 1 studies
| Studies (iclaprim) | Trials (iclaprim) | Recent Studies (post-2010) (iclaprim) | Studies (bc-3781) | Trials (bc-3781) | Recent Studies (post-2010) (bc-3781) |
|---|---|---|---|---|---|
| 45 | 7 | 16 | 41 | 10 | 41 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chew, KL; Octavia, S; Teo, JWP; Yeoh, SF | 1 |
1 other study(ies) available for iclaprim and bc-3781
| Article | Year |
|---|---|
MIC Values of Iclaprim and Lefamulin against Mycobacterium abscessus Complex.
Topics: Anti-Bacterial Agents; Diterpenes; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Polycyclic Compounds; Pyrimidines; Thioglycolates | 2021 |